NYSTATIN CREAM USP

Manufacturer
Actavis Pharma, Inc.
Effective date
2017-04-30
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
8
Source
legacy-cache
Hydrated at
2026-08-01 23:40:25

Label at a glance#

ProductNystatin
Active ingredientNYSTATIN
Label structure10 sections

Indications and uses

Nystatin Cream USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida (Monilia) albicans and other Candida species.

Dosage and administration

Nystatin Cream USP should be applied liberally to the affected areas twice a day or as indicated until healing is complete. Nystatin cream is usually preferred to nystatin ointment in candidiasis involving intertriginous areas; very moist lesions however are best treated with nystatin topical powder. The cream does not stain the skin or mucous membranes and it provides a simple, convenient means of treatment.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

(100,000 units/g)

Rx Only

DESCRIPTION

DESCRIPTION SECTION

EACH GRAM OF NYSTATIN CREAM USP CONTAINS: 100,000 units in an aqueous cream base of aluminum hydroxide gel, cetearyl alcohol (and) ceteareth-20, citric acid, glyceryl stearate, methylparaben, polyoxyl 40 stearate, propylene glycol, propylparaben, purified water, sodium citrate, sorbic acid, sorbitol solution, titanium dioxide and white petrolatum.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Nystatin is an antifungal antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It probably acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin is a polyene antibiotic of undetermined structural formula that is obtained from Streptomyces noursei, and is the first well tolerated antifungal antibiotic of dependable efficacy for the treatment of cutaneous, oral and intestinal infections caused by Candida (Monilia) albicans and other Candida species. It exhibits no appreciable activity against bacteria.

Nystatin provides specific therapy for all localized forms of candidiasis. Symptomatic relief is rapid, often occurring within 24 to 72 hours after the initiation of treatment. Cure is effected both clinically and mycologically in most cases of localized candidiasis.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Nystatin Cream USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida (Monilia) albicans and other Candida species.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Nystatin Cream USP is contraindicated in patients with a history of hypersensitivity to any of its components.

PRECAUTIONS

PRECAUTIONS SECTION

Should a reaction of hypersensitivity occur the drug should be immediately withdrawn and appropriate measures taken.

This preparation is not for ophthalmic use.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Nystatin is virtually nontoxic and nonsensitizing and is well tolerated by all age groups including debilitated infants, even on prolonged administration.

If irritation on topical application should occur, discontinue medication.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Nystatin Cream USP should be applied liberally to the affected areas twice a day or as indicated until healing is complete. Nystatin cream is usually preferred to nystatin ointment in candidiasis involving intertriginous areas; very moist lesions however are best treated with nystatin topical powder.

The cream does not stain the skin or mucous membranes and it provides a simple, convenient means of treatment.

HOW SUPPLIED

HOW SUPPLIED SECTION

Nystatin Cream USP 100,000 units/g

15 g tube (0.53 oz)

30 g tube (1.1 oz)

Store at controlled room temperature 15°-30°C (59°-86°F). Avoid exposure to excessive heat, 40°C (104°F).

Manufactured by:

G&W Laboratories, Inc.
111 Coolidge Street
South Plainfield, NJ 07080 USA

Distributed by:
Actavis Pharma, Inc.
Parsippany, NJ 07054 USA

Revised – April 2017

I600-4830/4835A GW7211

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Actavis

NDC 0472-0163-15

Nystatin Cream USP 100,000 unit per gram

Rx Only

For External Use Only
Not for Ophthalmic Use

15 g (0.53 oz)

15g
15g

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0472-0163-15GM - Gram0472-0163b87845c2-79fd-45a4-a767-33714f3e7b7412013-02-13
0472-0163-30GM - Gram0472-0163eed2ca4f-24d7-4c54-a17f-23fb36cc444b12013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
NYSTATINACTIVE INGREDIENTBDF1O1C72E4
NYSTATINACTIVE MOIETYBDF1O1C72E4
ALUMINUM HYDROXIDEINACTIVE INGREDIENT5QB0T2IUN04
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1S4
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP4
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE44
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T4
PETROLATUMINACTIVE INGREDIENT4T6H12BN9U4
POLYOXYL 40 STEARATEINACTIVE INGREDIENT13A4J4NH9I4
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V34
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH4
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULR4
SORBIC ACIDINACTIVE INGREDIENTX045WJ989B4
SORBITOLINACTIVE INGREDIENT506T60A25R4
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP4
WATERINACTIVE INGREDIENT059QF0KO0R4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0472-01630472-0163-15, 0472-0163-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 9 · 484 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / RECTAL271 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / INTRAMUSCULAR0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3ELIXIR / ORAL9306 mgExact identifier — unii candidate
81 equally ranked IID candidates
SORBIC ACIDSORBIC ACIDX045WJ989BSYRUP / ORAL80 mgExact identifier — unii candidate
19 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, COATED / ORALNAExact identifier — unii candidate
88 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TFILM, SOLUBLE / BUCCAL3 mgExact identifier — unii candidate
79 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION/ DROPS / TOPICAL0.01 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPASTE / DENTAL0.5 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPOINTMENT / TOPICAL1 mgExact identifier — unii candidate
88 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, DELAYED RELEASE / ORAL0.01 mgExact identifier — unii candidate
44 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPGRANULE, FOR SUSPENSION / ORAL143 mgExact identifier — unii candidate
40 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCREAM, AUGMENTED / TOPICAL15 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHTABLET, CHEWABLE / ORAL0.14 mgExact identifier — unii candidate
68 equally ranked IID candidates
SORBITOLSORBITOL506T60A25ROINTMENT / TOPICAL10 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, SOLUTION, CONCENTRATE / IRRIGATION1 mgExact identifier — unii candidate
88 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TJELLY / NASAL250 mgExact identifier — unii candidate
79 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSUSPENSION / RECTAL46.18 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPASTE, DENTIFRICE / DENTAL14 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUPPOSITORY / VAGINALNAExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CAPSULE, DELAYED RELEASE / ORAL15 mgExact identifier — unii candidate
21 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / OPHTHALMIC1 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3PASTE / DENTAL0.5 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSHAMPOO / TOPICAL17 mgExact identifier — unii candidate
88 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL23 mgExact identifier — unii candidate
21 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSUSPENSION / ORAL45000 mgExact identifier — unii candidate
44 equally ranked IID candidates
POLYOXYL 40 STEARATEPOLYOXYL 40 STEARATE TYPE I13A4J4NH9IGRANULE / ORALNAExact identifier — unii candidate
13 equally ranked IID candidates
SORBIC ACIDSORBIC ACIDX045WJ989BTABLET / ORAL10 mgExact identifier — unii candidate
19 equally ranked IID candidates
SORBITOLSORBITOL506T60A25REMULSION / TOPICAL7 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRAMUSCULAR28 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, CHEWABLE / ORAL7 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSUSPENSION / ORAL269 mgExact identifier — unii candidate
88 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TPOWDER, FOR SUSPENSION / ORAL75 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYSTEM / TOPICAL4200 mgExact identifier — unii candidate
81 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / NASAL250 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRAVENOUS95 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION, EXTENDED RELEASE / ORAL40 mgExact identifier — unii candidate
79 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSUSPENSION/ DROPS / ORAL19 mgExact identifier — unii candidate
88 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRAMUSCULAR95 mgExact identifier — unii candidate
79 equally ranked IID candidates
POLYOXYL 40 STEARATEPOLYOXYL 40 STEARATE TYPE I13A4J4NH9IAEROSOL, FOAM / TOPICAL2.83 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED, EXTENDED RELEASE / ORAL11 mgExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSOAP / TOPICAL1 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CREAM / VAGINAL140 mgExact identifier — unii candidate
21 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / INTRAVENOUS50.33 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, DELAYED RELEASE / ORAL1.7 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHLOTION / TOPICAL140 mgExact identifier — unii candidate
68 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / EPIDURAL0.02 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RINJECTION, SOLUTION / INTRAVENOUS4050 mgExact identifier — unii candidate
44 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION, SOLUTION / INTRAVENOUS5 mgExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / SOFT TISSUE0.15 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INFILTRATION80 mgExact identifier — unii candidate
79 equally ranked IID candidates
POLYOXYL 40 STEARATEPOLYOXYL 40 STEARATE TYPE I13A4J4NH9ISUSPENSION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM, SOLUBLE / BUCCAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
SORBIC ACIDSORBIC ACIDX045WJ989BEMULSION / OPHTHALMIC1 mgExact identifier — unii candidate
19 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION/ DROPS / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHOINTMENT / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, SOLUTION / SUBCUTANEOUS26 mgExact identifier — unii candidate
88 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPOINTMENT / TOPICAL5 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCAPSULE, EXTENDED RELEASE / ORAL0.22 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / VAGINAL6.4 %w/wExact identifier — unii candidate
81 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062949-001NYSTATINNYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A062949-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13c2088c7a36db…
2026-09-14 22:38:342026-08A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-1384e616aacf4f…
2026-08-18 06:07:402026-07A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-132680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-135bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-1379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-131e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-138072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-135c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-135d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-134b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-1374a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-1387673890dc5c…
2021-03-12 10:30 UTC2021-03A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-135aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-138869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-133f01610625f2…
2019-09-15 20:21 UTC2019-09A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13b00525d2431f…
2019-07-19 19:46 UTC2019-07A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-136a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-131c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-139b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-133f0d92c62455…
2023-05-13 08:27 UTC2023-05A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-13053a50430f4f…
2023-01-26 05:58 UTC2023-01A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-133bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062949-001NYSTATIN100,000 UNITS/GMCREAM / TOPICALAT1988-06-133a93d1ddd44b…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09A062949-001AT1c2088c7a36db…
2026-09-14 22:38:342026-08A062949-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A062949-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062949-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062949-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A062949-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062949-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062949-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062949-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062949-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062949-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062949-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062949-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062949-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062949-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062949-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062949-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062949-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062949-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062949-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062949-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062949-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062949-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062949-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A062949-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062949-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062949-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062949-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A062949-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A062949-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062949-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062949-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062949-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062949-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062949-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062949-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062949-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A062949-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A062949-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062949-001AT13a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e358ed42-af82-4c96-b78d-c3a8a84fed51a4cba0e2-d280-419f-819b-b0104b0314682017-04-30Adverse reactionsExact identifier
spl id: e358ed42-af82-4c96-b78d-c3a8a84fed51
spl set id: a4cba0e2-d280-419f-819b-b0104b031468

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.